Monday, October 5, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Applied Materials Announces First Quarter 2026 Results

View original at finance.yahoo.com
Applied Materials Announces First Quarter 2026 Results Applied Materials, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Applied Materials delivered strong results in fiscal first quarter, fueled by the acceleration of industry investments in AI computing

    80% confidence

  • Applied Materials is the process equipment leader in leading-edge logic, high-bandwidth memory and advanced packaging

    80% confidence

  • Over the past several years, Applied Materials has nearly doubled its system manufacturing capability, strengthened supply chain and increased inventories in preparation for market growth

    80% confidence

  • Applied Materials expects to grow its semiconductor equipment business over 20 percent in calendar year 2026

    80% confidence

  • The need for higher performance and more energy-efficient chips is driving high growth rates for leading-edge logic, high-bandwidth memory and advanced packaging

    80% confidence

  • Applied Materials is focused on ensuring capacity to support customers with increasing demand for innovative products and services

    80% confidence

Data points we hold from this source

Applied Materials, Inc. · revenue7.012 billion_USD
Applied Materials, Inc. · stockholders equity21.717 billion_USD
Applied Materials, Inc. · employee count35500 employees
Applied Materials, Inc. · taiwan revenue1.722 billion_USD
Applied Materials, Inc. · total assets37.644 billion_USD
Applied Materials, Inc. · total debt6.553 billion_USD
Applied Materials, Inc. · us revenue0.656 billion_USD
Applied Materials, Inc. · gross margin49.0 percent
Applied Materials, Inc. · inventories5.997 billion_USD
Applied Materials, Inc. · japan revenue0.525 billion_USD
Applied Materials, Inc. · korea revenue1.458 billion_USD
Applied Materials, Inc. · net income2.026 billion_USD
Applied Materials, Inc. · non gaap eps2.38 USD
Applied Materials, Inc. · non gaap free cash flow1.040 billion_USD
Applied Materials, Inc. · non gaap gross margin49.1 percent
Applied Materials, Inc. · non gaap net income1.899 billion_USD
Applied Materials, Inc. · non gaap operating margin30.0 percent
Applied Materials, Inc. · operating cash flow1.686 billion_USD
Applied Materials, Inc. · operating margin26.1 percent
Applied Materials, Inc. · cash and equivalents7.218 billion_USD
Applied Materials, Inc. · china revenue2.095 billion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com
Applied Materials Announces First Quarter 2026 Results — Source | Via News | Via News